Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Defined Benefit Plan, Funded (Unfunded) Status of Plan

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Funded (Unfunded) Status of Plan

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Funded (Unfunded) Status of Plan of -$32.17 million as of 2025-12-27, per its 10-K filed 2026-02-18.

Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan

us-gaap:DefinedBenefitPlanFundedStatusOfPlan · last filed 2026-02-18

  • 2025-12-27: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$32.17M.
  • 2024-12-28: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$33.31M.
  • 2023-12-30: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$21.22M.
  • 2022-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$13.01M.
Period endDefined Benefit Plan, Funded (Unfunded) Status of Plan
2025-12-27-$32.17M
10-K · filed 2026-02-18
2024-12-28-$33.31M
10-K · filed 2026-02-18
2023-12-30-$21.22M
10-K · filed 2025-02-19
2022-12-31-$13.01M
10-K · filed 2024-02-14
2021-12-25-$36.97M
10-K · filed 2023-02-22
2020-12-26-$42.72M
10-K · filed 2022-02-16
2019-12-28-$90.23M
10-K · filed 2021-02-17
2018-12-29-$57.10M
10-K · filed 2020-02-11
2017-12-30-$88.64M
10-K · filed 2019-02-13
2016-12-31-$123.04M
10-K · filed 2018-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71